Article
Licensed
Unlicensed
Requires Authentication
Information comparison of the effects of drugs on laboratory tests in drug labels and Young’s book
-
Arjen F.J. Geerts
,
Fred H.P. De Koning
Published/Copyright:
May 11, 2012
Abstract
Background: The effects of drugs on laboratory tests may lead to misinterpretation of laboratory data, unnecessary tests, higher costs and missed diagnoses. This study compared the information on drug-laboratory effects (DLE) described in 200 drug labels with that in Young’s book.
Methods: Information on DLE was searched in the drug labels of 200 frequently prescribed drugs using the keywords ‘interfer*’, ‘influence’, and ‘laborator*’. This information was compared with the information in Young’s book. Each item of information scored 1 point if it was specific and exactly the same. Primary outcome was the percentage of DLE with completely the same information.
Results: In 23 (11.5%) of the 200 drug labels 83 DLE were described. Most DLE were described in drug labels of contraceptives (71%) and antibacterials (15%). The most frequently affected laboratory tests were adrenal gland (17%), urine tests (15%), liver tests (10%) and renal function tests (10%). Comparison of six DLE with Young’s book was not possible because the information was not described in the book. Twelve (14.5%) DLE of the information in the drug label was identical to that in Young’s book. Detailed information about nature of the effect, strength of the effect and body fluid was not described in the drug labels.
Conclusions: In a limited number of DLE in the drug labels the information was the same as in Young’s book. Overall, the information on DLE provided in drug labels is unclear, inconsistent and incomplete and does not support healthcare professionals in making evidence-based monitoring decisions.
Keywords: analytical phase; data monitoring; drug interference, drug labels; drug-laboratory effects; result interpretation
Received: 2012-1-16
Accepted: 2012-4-17
Published Online: 2012-05-11
Published in Print: 2012-10-01
©2012 by Walter de Gruyter Berlin Boston
You are currently not able to access this content.
You are currently not able to access this content.
Articles in the same Issue
- Masthead
- Masthead
- Editorials
- Cancer epigenomics: moving slowly, but at a steady pace from laboratory bench to clinical practice
- Laboratory networking and sample quality: a still relevant issue for patient safety
- Reviews
- DNA methylation biomarkers and their utility for solid cancer diagnostics
- DNA methylation biomarkers in biological fluids for early detection of respiratory tract cancer
- Global DNA hypomethylation in cancer: review of validated methods and clinical significance
- Genetics and Molecular Diagnostics
- δ0-Thalassemia in cis of βKnossos globin gene: first homozygous description in thalassemia intermedia Libyans and first combination with codon 39 (C→T) in thalassemia intermedia Tunisian patients
- Genetic-based reference values for angiotensin-converting enzyme (ACE) according to I/D polymorphism in a Spanish population sample
- General Clinical Chemistry and Laboratory Medicine
- Effects of sample transportation on commonly requested laboratory tests
- Long-term (in)stability of folate and vitamin B12 in human serum
- Information comparison of the effects of drugs on laboratory tests in drug labels and Young’s book
- First evaluation of Capillarys 2 Flex Piercing® (Sebia) as a new analyzer for HbA1c assay by capillary electrophoresis
- Antioxidant and oligonutrient status, distribution of amino acids, muscle damage, inflammation, and evaluation of renal function in elite rugby players
- Validation of the body fluid module on the new Sysmex XN-1000 for counting blood cells in cerebrospinal fluid and other body fluids
- Measuring Rivaroxaban in a clinical laboratory setting, using common coagulation assays, Xa inhibition and thrombin generation
- Cancer Diagnostics
- Increased concentrations of growth factors and activation of the EGFR system in breast cancer
- Infectious Diseases
- Incidence and significance of elevated lactate in the identification of critically ill patients
- Cardiovascular Diseases
- Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosis
- Diabetes
- Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes
- Letters to the Editor
- Establishing professional phlebotomist group for quality control of the preanalytic variables of clinical laboratory
- Application of quality specification based on biological variation in planning quality control strategy
- Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of infliximab and adalimumab
- Comparison of relationships between FT4 and log TSH in Access DXI 800 Unicel, Modular E170 and ADVIA Centaur XP Analyzer
- Assay-specific pitfalls of catecholamine HPLC assays
- Evaluation of automated nucleated red blood cells counting on Sysmex XE5000 and Siemens ADVIA 2120
- Evaluation of the immature myeloid information (IMI) by Sysmex XE 2100® hematology analyzer in the identification of blasts of myeloid lineage
- Congress Abstracts
- Congress of Laboratory Medicine and Clinical Chemistry / 4th Annual Meeting of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC)
- Abstracts of the 2012 Convocation of Experts on Laboratory Quality / Embracing the Need of Continued Vigilance to Assure Quality Outcomes in the Modern Laboratory
Keywords for this article
analytical phase;
data monitoring;
drug interference, drug labels;
drug-laboratory effects;
result interpretation
Articles in the same Issue
- Masthead
- Masthead
- Editorials
- Cancer epigenomics: moving slowly, but at a steady pace from laboratory bench to clinical practice
- Laboratory networking and sample quality: a still relevant issue for patient safety
- Reviews
- DNA methylation biomarkers and their utility for solid cancer diagnostics
- DNA methylation biomarkers in biological fluids for early detection of respiratory tract cancer
- Global DNA hypomethylation in cancer: review of validated methods and clinical significance
- Genetics and Molecular Diagnostics
- δ0-Thalassemia in cis of βKnossos globin gene: first homozygous description in thalassemia intermedia Libyans and first combination with codon 39 (C→T) in thalassemia intermedia Tunisian patients
- Genetic-based reference values for angiotensin-converting enzyme (ACE) according to I/D polymorphism in a Spanish population sample
- General Clinical Chemistry and Laboratory Medicine
- Effects of sample transportation on commonly requested laboratory tests
- Long-term (in)stability of folate and vitamin B12 in human serum
- Information comparison of the effects of drugs on laboratory tests in drug labels and Young’s book
- First evaluation of Capillarys 2 Flex Piercing® (Sebia) as a new analyzer for HbA1c assay by capillary electrophoresis
- Antioxidant and oligonutrient status, distribution of amino acids, muscle damage, inflammation, and evaluation of renal function in elite rugby players
- Validation of the body fluid module on the new Sysmex XN-1000 for counting blood cells in cerebrospinal fluid and other body fluids
- Measuring Rivaroxaban in a clinical laboratory setting, using common coagulation assays, Xa inhibition and thrombin generation
- Cancer Diagnostics
- Increased concentrations of growth factors and activation of the EGFR system in breast cancer
- Infectious Diseases
- Incidence and significance of elevated lactate in the identification of critically ill patients
- Cardiovascular Diseases
- Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosis
- Diabetes
- Serum cystatin C as a marker for early detection of chronic kidney disease and grade 2 nephropathy in Japanese patients with type 2 diabetes
- Letters to the Editor
- Establishing professional phlebotomist group for quality control of the preanalytic variables of clinical laboratory
- Application of quality specification based on biological variation in planning quality control strategy
- Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of infliximab and adalimumab
- Comparison of relationships between FT4 and log TSH in Access DXI 800 Unicel, Modular E170 and ADVIA Centaur XP Analyzer
- Assay-specific pitfalls of catecholamine HPLC assays
- Evaluation of automated nucleated red blood cells counting on Sysmex XE5000 and Siemens ADVIA 2120
- Evaluation of the immature myeloid information (IMI) by Sysmex XE 2100® hematology analyzer in the identification of blasts of myeloid lineage
- Congress Abstracts
- Congress of Laboratory Medicine and Clinical Chemistry / 4th Annual Meeting of the Austrian Society for Laboratory Medicine and Clinical Chemistry (ÖGLMKC)
- Abstracts of the 2012 Convocation of Experts on Laboratory Quality / Embracing the Need of Continued Vigilance to Assure Quality Outcomes in the Modern Laboratory
